Condition,KE title,number of genes,number of significant genes,number of significant genes down,number of significant genes up,Percentage significant,Percentage upregulated,Percentage downregulated,a (sig & in KE),b (sig & not in KE),c (non-sig & in KE),d (non-sig & not in KE),Enrichment p-value,Odds ratio
hyperthyroid,Reduced levels of BDNF,144,1,0,1,0.7,0.7,0.0,1,63,143,37217,0.2188,4.1311
hyperthyroid,Decreased cell proliferation,120,0,0,0,0.0,0.0,0.0,0,64,120,37240,1.0000,0.0
hyperthyroid,Decreased synaptogenesis,27,0,0,0,0.0,0.0,0.0,0,64,27,37333,1.0000,0.0
hyperthyroid,Hypomyelination,30,0,0,0,0.0,0.0,0.0,0,64,30,37330,1.0000,0.0
hypothyroid,Decreased cell proliferation,120,31,24,7,25.8,5.8,20.0,31,2963,89,34341,0.0000,4.0369
hypothyroid,Reduced levels of BDNF,144,34,22,12,23.6,8.3,15.3,34,2960,110,34320,0.0000,3.5838
hypothyroid,Hypomyelination,30,6,3,3,20.0,10.0,10.0,6,2988,24,34406,0.0292,2.8787
hypothyroid,Decreased synaptogenesis,27,4,2,2,14.8,7.4,7.4,4,2990,23,34407,0.1657,2.0013
